Key statistics
As of last trade Oculis Holding AG (CR5:FRA) traded at 23.00, -11.54% below its 52-week high of 26.00, set on Jan 28, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 23.00 |
|---|---|
| High | 23.00 |
| Low | 23.00 |
| Bid | 23.60 |
| Offer | 25.10 |
| Previous close | 25.20 |
| Average volume | 105.67 |
|---|---|
| Shares outstanding | 57.81m |
| Free float | 56.22m |
| P/E (TTM) | -- |
| Market cap | 1.65bn USD |
| EPS (TTM) | -2.82 USD |
Data delayed at least 15 minutes, as of Feb 17 2026 07:05 GMT.
More ▼
- Oculis Appoints Katie Kazem as Chief Legal Officer
- Oculis Appoints Katie Kazem as Chief Legal Officer
- Oculis to Showcase Transformative Late-stage Pipeline in Neuro-ophthalmology and Ophthalmology at the 2026 J.P. Morgan Healthcare Conference
- Oculis to Showcase Transformative Late-stage Pipeline in Neuro-ophthalmology and Ophthalmology at the 2026 J.P. Morgan Healthcare Conference
- Oculis Announces U.S. FDA Breakthrough Therapy Designation Granted to Privosegtor for Treatment of Optic Neuritis
- Oculis Announces U.S. FDA Breakthrough Therapy Designation Granted to Privosegtor for Treatment of Optic Neuritis
- Oculis tilkynnir um að Matvæla- og lyfjastofnun Bandaríkjanna (FDA) hafi veitt Privosegtor stöðu byltingarkennds meðferðarlyfs til meðhöndlunar á sjóntaugabólgu
- Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
- Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
- Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
More ▼
